Comparing the efficacy and safety of nafamostat mesylate versus citrate for anticoagulation in continuous renal replacement therapy: a systematic review and meta-analysis - Quiz - MDSpire

Comparing the efficacy and safety of nafamostat mesylate versus citrate for anticoagulation in continuous renal replacement therapy: a systematic review and meta-analysis

  • By

  • Zhao Hua Zou

  • Ji Quan Zhang

  • Pei Jun Xiang

  • Xing Chen

  • Wei Qing

  • July 6, 2026

  • 0 min

Share

Original Source(s)

Comparing the efficacy and safety of nafamostat mesylate versus citrate for anticoagulation in continuous renal replacement therapy: a systematic review and meta-analysis

  • by Zhao Hua Zou, Ji Quan Zhang, Pei Jun Xiang, Xing Chen, Wei Qing

  • July 6, 2026

Related Content

The role and therapeutic potential of nanotechnology-mediated ferroptosis regulation in myelodysplastic syndromes

Freely accessible large language models for parent education in pediatric immune thrombocytopenia: an expert-rated cross-sectional study of safety, readability, and guideline concordance

Optimizing ciltacabtagene autoleucel outcomes: real-world experience and best practices from a single academic center